Tecan Group AG (LON:0QLN)

Market Cap	1.91B
Revenue (ttm)	823.54M
Net Income (ttm)	59.64M
Shares Out	n/a
EPS (ttm)	4.66
PE Ratio	32.08
Forward PE	21.29
Dividend	2.79 (1.63%)
Ex-Dividend Date	Apr 14, 2025

Volume	14,908
Average Volume	18,389
Open	168.70
Previous Close	170.20
Day's Range	165.00 - 168.70
52-Week Range	134.30 - 335.80
Beta	0.96
RSI	51.39
Earnings Date	Jun 12, 2025

About Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized O...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1980
• Employees: 3,341
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0QLN

Financial Performance

In 2024, Tecan Group AG's revenue was 934.28 million, a decrease of -13.04% compared to the previous year's 1.07 billion. Earnings were 67.66 million, a decrease of -48.77%.

Financial numbers in CHF